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In chronic serum sickness, glomerular immune complexes
form, yet C57BL/6 mice do not develop glomerulonephritis
unless complement factor H (CfH) is absent, indicating the
relevance of complement regulation. Complement receptor
3 (CD11b) and Fcc receptors on leukocytes, and CfH on
platelets, can bind immune complexes. Here we induced
immune complex–mediated glomerulonephritis in CfH /
mice chimeric for wild-type, CfH / , CD11b / , or
FcRc / bone marrow stem cells. Glomerulonephritis
was worse in CD11b / chimeras compared with all others,
whereas disease in FcRc / and wild-type chimeras was
comparable. Disease tracked strongly with humoral immune
responses, but not glomerular immune complex deposits.
Interstitial inflammation with M1 macrophages strongly
correlated with glomerulonephritis scores. CD11b /
chimeras had significantly more M1 macrophages and CD4þ
T cells. The renal dendritic cell populations originating from
bone marrow–derived CD11cþ cells were similar in all
experimental groups. CD11bþ cells bearing colony-
stimulating factor 1 receptor were present
in kidneys, including CD11b / chimeras; these cells
correlated negatively with glomerulonephritis scores.
Thus, experimental immune complex–mediated
glomerulonephritis is associated with accumulation of
M1 macrophages and CD4þ T cells in kidneys and functional
renal insufficiency. Hence, CD11b on mononuclear cells is
instrumental in generating an anti-inflammatory response
in the inflamed kidney.
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Complement activation through each of the three pathways
leads to the generation of C3 and C5 products. These mark
infectious microorganisms as foreign and alert innate and
adaptive immune cells to their presence. Spontaneous
alternative pathway activation is regulated by complement
factor H (CfH). When CfH is ineffective in the fluid phase,
products of unrestricted C3 activation can deposit in the
glomerular capillary wall, as in C3 glomerulopathies.1 Factor
H is also retained by the glomerular and other capillary wall
surfaces; when this is inefficient, endothelial cell injury and
atypical hemolytic uremic syndrome can result.
Anaphylatoxin receptors C3aR and C5aR signal through
a subset of pertussis toxin–sensitive GTP-binding protein
a-subunits.2 The b2 integrin (CD18) heterodimers with aM
(CD11b) and aX (CD11c) were first termed complement
receptors (CR) 3 and 4 by virtue of their binding to
inactivated (i) C3b.3 Although traditionally considered
adherence receptors, CD11b/CD11c binding to ligand can
lead to ‘outside-in’ signals via immunoreceptor tyrosine-
based activation motif proteins; these include the Fc receptor
common g-chain (FcRg) and DNAX-activating protein
of 12 kDa (DAP12) (encoded by Fcer1g and Tyrobp,
respectively).4,5
Induction of chronic serum sickness (CSS) leads to
deposition of immune complexes (ICs) in glomeruli.6 Yet,
there is no uniform development of inflammation and
glomerulonephritis (GN); for instance, C57BL/6 mice do not
develop GN in CSS,7 whereas all CfH-deficient mice with CSS
develop diffuse proliferative GN within 5 weeks.8 The GN in
CSS is characterized by accumulation of IgG/C3-containing
ICs together with F4/80þ macrophages.9,10 Disease requires
signals through C5aR, as C5aR /CfH / mice with CSS
do not develop GN.10
Humans use CR1 on erythrocytes for IC processing; in
contrast, the rodent relies upon CfH on platelets.11,12 As
such, CfH / mice lacking platelet CfH have markedly
abnormal IC processing. Platelet CfH is restored in CfH /
mice chimeric for wild-type bone marrow (BM).9 These
animals still lack hepatic-produced plasma CfH. When CSS is
induced in CfH / mice with wild-type BM, IC metabolism
approaches that in wild-type mice, such that there are
considerably fewer glomerular ICs. Yet, these animals still
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develop GN.9 In contrast, wild-type mice with CfH / BM
failed to develop GN, despite the presence of large quantities
of ICs (attributable to abnormal IC processing from CfH-
deficient platelets).9 This illustrates the importance of
complement regulation by plasma CfH in the setting of
glomerular-bound ICs. The abundant ICs containing IgG
and iC3b as ligands for inflammatory cell FcgRs and b2
integrins are inert. The presence of active C3b is required to
generate C5a as the necessary signal that initiates inflamma-
tion in GN.9,10
On the basis of these data, we hypothesized that in CSS-
induced GN (1) leukocyte FcgRs and b2 integrins are
activated by C5aR signaling; (2) all three are necessary, such
that disease will not occur in the absence of any one;
(3) although FcgRs and b2 integrins are relevant to systemic
IC metabolism, this is of less consequence in this model; and
(4) FcgRIII and CD11b were the most likely relevant FcgRs
and b2 integrins. To evaluate this, we studied CSS in CfH
 /
mice chimeric for FcRg / and CD11b / BM. Surpris-
ingly, disease was considerably worse in the latter group.
RESULTS
Increased anti-apoferritin IgG antibodies and circulating ICs
in the absence of CfH or CD11b on BM-derived cells
We lethally irradiated CfH / mice and reconstituted their
BM with CD117þ stem cells from wild-type (n¼ 8),
CfH / (n¼ 12), FcRg / (n¼ 7), and CD11b /
(n¼ 7) mice. After stable hematopoeitic cell engraftment,
CSS was induced by actively immunizing mice with a daily
intraperitoneal dose of 4mg of horse spleen apoferritin.
CfH / mice with CfH / BM receiving saline vehicle
alone were used as control (n¼ 5). As expected, these control
CfH / chimeras did not generate antibodies to apoferritin.
All animals immunized with apoferritin generated an anti-
apoferritin antibody response (Figure 1). As predicted from
past data,8,9 CfH / chimeras had higher antibody levels
than wild-type mice. Yet, the highest levels were observed in
the CD11b / chimeras (Figure 1, Po0.001).
As expected, all animals with CSS had IgG-containing ICs
in plasma. Anti-apoferritin IgG levels and ICs were positively
correlated (Supplementary Figure S1a online). As with the
anti-apoferritin IgG, CfH / and CD11b / chimeric mice
had the highest IC levels compared with wild-type and
FcRg / mice.
We were surprised that CD11b / chimeras had the
highest anti-apoferritin IgG levels. To examine the role for
absent plasma CfH in these findings, we induced CSS in wild-
type, CfH / , and CD11b / mice (i.e., that were not BM
chimeras; n¼ 6 each). Serum anti-apoferritin IgG levels were
no different between wild-type and CD11b / mice
(29.5±1.4 and 31.2±1.6U/ml, respectively). As we have
seen before,8 CfH / mice had higher anti-apoferritin IgG
(52.4±4.2, Po0.001 by analysis of variance). These anti-
apoferritin IgG levels also strongly correlated with circulating
C1q- and IgG-containing ICs (R¼ 0.73), with a slope
comparable to the BM chimera studies (0.759 vs. 0.743)
(Supplementary Figure S1b online). Thus, the absence of
CD11b on BM-derived cells together with absent plasma
CfH led to a heightened humoral immune response to the
heterologous apoferritin.
Glomerular ICs in CSS
Because of the absence of plasma CfH in all BM chimeric
animals, including controls receiving saline, all mouse
glomeruli had strongly positive capillary wall staining for
C3 (Figure 2a). The IgG deposits in wild-type chimeric mice
were largely within the mesangium, whereas CfH /
chimeras had strongly positive mesangial IgG (Figure 2a,
asterisks), which extended to the peripheral capillary wall.
This is attributable to the absence of CfH on platelets,
resulting in impaired IC processing in these mice.9,11
The intensity of IgG staining was similar in the three
groups with CSS but intact platelet CfH (i.e., wild-type,
FcRg / , and CD11b / ; quantified in Figure 2b), with
extension of IgG from the mesangium to the peripheral
capillary loops, where it appeared to be present in ICs, as
evidenced by dual staining for IgG and C3 (Figure 2a,
arrows). In the CD11b / chimeric mice, there was greater
extension of granular IgG (and C3) deposits into the
peripheral capillary wall (Figure 2a, arrowheads).
The intensity and localization of IgG within glomeruli in
CSS was similar in wild-type, CfH / , and CD11b / mice
relative to their respective BM chimeras (Figure 2c). As with
CD11b / BM chimeras, CD11b / mice had greater
peripheral glomerular capillary wall extension of IgG,13
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Figure 1 | Higher anti-apoferritin antibody levels in chronic
serum sickness (CSS) induced in complement factor H (CfH) /
mice with CfH / and CD11b / bone marrow. Animals were
actively immunized with daily intraperitoneal doses of 4mg of horse
spleen apoferritin in saline. Five weeks later, anti-apoferritin IgG levels
were measured. Data from individual mice are shown. These data
from each group were normally distributed (Anderson–Darling test
P40.08). *Po0.001 versus all other groups, analysis of variance
followed by Tukey’s all-pairwise approach.
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although this was not statistically different from wild-type
mice. Glomerular C3 staining in wild-type and CD11b /
mice colocalized with IgG (yellow color in merged images in
Figure 2c). In all experimental animals lacking plasma CfH,
there was no C3 or IgG staining within the extraglomerular
vessels or in the tubulointerstitium. The segmental linear
staining for C3 seen in normal mouse peritubular and
periglomerular regions was also absent, consistent with the
absence of plasma CfH.14,15
Worsened renal disease in the absence of plasma CfH and
CD11b on BM-derived cells
Control mice did not develop renal disease, as evidenced by
normal blood urea nitrogen (BUN) values (26.1±0.8mg/dl,
Figure 3a). All animals with CSS developed renal insuffi-
ciency, with increased BUN values (Figure 3a). Wild-type
and FcRg / chimeric mice had comparably increased
BUN values (36.5±1.2 and 37.3±1.1mg/dl, respectively).
CfH / chimeras with CSS had BUN values (42.7±1.2mg/dl)
that were significantly different from wild type, indicating the
relevance of CfH on BM-derived cells. Surprisingly, each
of the seven CD11b / chimeric mice had higher BUN
levels than any of the other 27 animals (Figure 3a) (mean±
s.e.m.¼ 53.3±1.5mg/dl). As we have observed before, anti-
apoferritin IgG levels strongly correlated with BUN values
(Supplementary Figure S2 online).8
Control CfH / chimeras receiving saline instead of
apoferritin had normal urinary albumin excretion (13.5±
1.5 mg/mg creatinine). Albuminuria was 30.5±6.5, 44.3±5.8,
and 74.0±4.7 mg/mg creatinine in wild-type, CfH / , and
CD11b / BM chimeras with CSS, respectively (Po0.001,
one-way analysis of variance; Po0.03, CD11b / vs. all
other groups). In CSS induced in native wild-type, CfH / ,
and CD11b / mice (i.e., that did not receive BM transfers),
urinary albumin was 15.4±1.7, 32.9±2.5, and 26.6±1.6 mg/
mg creatinine, respectively (Po0.001, one-way analysis of
variance; Po0.005, wild type vs. CfH / and CD11b / ).
All animals lacking plasma CfH (i.e., all BM chimeras and
CfH / mice without BM transfer) in which CSS was
induced developed diffuse proliferative GN (Figure 3b).
There was little to no interstitial inflammation in any of the
groups, except for the CD11b / chimeras in which there
were focal periglomerular mononuclear cell infiltrates
(Figure 3b, arrow). There was no appreciable interstitial
fibrosis, tubular atrophy, or arteritis in any kidney. Native
wild-type and CD11b / mice did not develop GN in CSS
(median GN scores 0 and 0.5, respectively; P¼ 0.002 vs.
CfH / mice studied contemporaneously).
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Figure 2 | Glomerular immune complex deposition in chronic serum sickness (CSS). (a) Representative immunofluorescence
photomicrographs from complement factor H (CfH) / mice chimeric for wild-type (WT), CfH / , FcgR / , and CD11b / bone marrow,
or (c) native WT, CfH / , and CD11b / mice (i.e., without bone marrow transfer) actively immunized with apoferritin to induce chronic
serum sickness, or saline as control. Dual staining for C3 (green) and IgG (red) is shown; the yellow color indicates immune complexes
containing IgG and C3. Because animals lacked plasma CfH, there was strongly positive glomerular C3 staining in all groups. The asterisks and
arrows depict mesangial and peripheral capillary wall immune complex deposits, respectively. The arrowheads show the more granular
peripheral capillary wall immune complex staining in CD11b / chimeras. (b, c) Semiquantitative scoring for IgG staining intensity from
individual mice from all groups. In b, data are shown as median (horizontal line), and Q3-Q1 in the boxes, whereas in c these are presented
below the figures. Group medians were significantly different (P¼ 0.02, Mood Median test). *Po0.05 versus all other groups.
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Notably, these three measures of renal disease—BUN
concentrations, albuminuria, and GN scores—were highly
related (R values X0.81, see legend to Supplementary Figure
S2 online). BUN and urinary albumin were the most strongly
correlated (BUN¼ 20.9þ (0.47 UAlb), R¼ 0.97). It is
notable that each measurement is derived from a distinct
anatomic site (i.e., blood, urine, and renal tissue). Thus, in
this model, the extent of histopathological GN tracks with
functional renal disease.
Increased interstitial mononuclear cell infiltrates in the
absence of CD11b on BM-derived cells
In the CSS model, there is IC deposition, complement
activation, and inflammation in the glomeruli. Although
there is no histopathological evidence of tubulointerstitial
nephritis, the mononuclear cell compartment as measured by
flow cytometry expands and is related to disease features in
this model.10 Thus, we examined mononuclear cells in the
renal interstitium 5 weeks after induction of CSS. There were
F4/80þ and CD115þ cells, but not F4/80þCD115þ cells
(Supplementary Figure S3 online). The F4/80þ cells were
distinguished by CCR2 and Ly6C staining (Figure 4a). There
were few Ly6ChiCCR2hi M1 (inflammatory) macrophages in
the kidneys of CfH / mice with CfH / BM, with or
without CSS (Figure 4a, red boxes). This is consistent with
our past work with CfH / mice with CSS.9 Yet, the wild-
type, FcRg / , and CD11b / chimeric mice had an
increased number of Ly6ChiCCR2hi M1 macrophages
(Figure 4a, red arrows), which was significantly greater in
CD11b / chimeras (Figure 4b). As anticipated, these cells
were CD11b (Figure 4c, red arrowhead). The proportion of
F4/80þ cells that were Ly6ChiCCR2hi M1 macrophages
positively correlated with GN scores (Figure 5a), supporting
that glomerular and tubulointerstitium (TI) inflammation
were linked.
There were also Ly6CþCCR2 cells (Figure 4a, black
boxes) comprising two distinct populations, namely Ly6Cþ
CD11bþCD11c (except in CD11b / chimeras) and
Ly6ChiCD11bCD11clo (Supplementary Figure S4 online).
The former is consistent with M2 macrophages, whereas the
identity of the latter is unclear.
The Ly6C cellular population contained both CCR2
and CCR2þ cells (Figure 4a, blue boxes). Overall, these cells
are typical for native kidney dendritic cells.16,17 The majority
were CD11bþCD11cþ , although there were different
patterns in the different groups (Supplementary Figure S5a
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Figure 3 |Worsened glomerulonephritis in complement factor H (CfH) / mice with CfH / and CD11b / bone marrow. CfH /
mice chimeric for wild-type (WT), CfH / , FcgR / , and CD11b / bone marrow were actively immunized with apoferritin to induce chronic
serum sickness, or saline as control. (a) After 5 weeks, blood urea nitrogen (BUN) was measured. Data from individual mice are shown. These
data from each group were normally distributed (Anderson–Darling test P40.04), whereas the population means were unequal (one-way
analysis of variance, Po0.001). The Tukey all-pairwise approach was used to compare individual means. *Po0.007 versus all other groups.
(b) Representative histopathology is shown. Diffuse endocapillary proliferative glomerulonephritis was evident in all groups receiving
apoferritin. The white arrow shows periglomerular infiltrates in CD11b / chimeras. Semiquantitative scores for GN are provided as median,
with Q3-Q1 interval in parentheses. Group medians were significantly different (P¼ 0.003, the Mood Median test). *Po0.05 versus all
other groups.
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online). In the CD11b / chimeras, these cells were
CD11b and had greater surface CD11c staining than wild
type (Supplementary Figure S5b online).
In all groups, the CD115þF4/80 cells were CD11bþ
CD11c (Supplementary Figure S3b online), Ly6C , and
CCR2 (data not shown). Interestingly, even CD11b /
chimeras had these CD115þF4/80CD11bþ cells, albeit in
lesser quantities (Supplementary Figure S3b online). Thus,
this particular cellular population is radioresistant. The
number of CD115þF4/80CD11bþ cells negatively corre-
lated with GN scores (Figure 5b) and M1 macrophages
(R¼  0.86), suggesting this is an anti-inflammatory popu-
lation. Morever, GN scores in a given animal could be
accurately predicted by the two-component model,
GN¼ 1.37—(0.044 x CD115þ )þ (0.047 BUN) (R¼ 0.92,
Po0.001).
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Figure 4 | Characterization of F4/80þ cells in the tubulointerstitium of kidneys from complement factor H (CfH) / mice chimeric
for wild-type (WT), CfH / , FcgR / , and CD11b / bone marrow immunized for 5 weeks with apoferritin, or saline as control.
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are also provided as ‘Mean±s.e.m.’ in the adjacent columns. *Po0.01 versus all other groups (one-way analysis of variance followed by
Tukey’s all-pairwise testing). (c) Ly6ChiCCR2hi M1 macrophages (quadrant 2, red arrows) were analyzed for CD11c (y-axis) and CD11b (x-axis)
staining. The red arrowhead depicts Ly6ChiCCR2hiCD11cþCD11b cells in CD11b / chimeras.
4
3
2
G
lo
m
er
ul
on
ep
hr
itis
 (0
–4
)
1
0
4
3
2
1
0
0 5 10 20 25
Ly6ChiCCR2hi (% of F4/80+) CD115+ (% of CD3–CD19–)
30 35 4015 0 5 10 20 25 30 35 40 45
CfH–/– saline
CfH–/–
WT
CD11b–/–
FcγR–/–
50 55 6015
Figure 5 | Correlation between tubulointerstitium (TI) mononuclear cells and glomerulonephritis scores. (a) The number of Ly6ChiCCR2hi
M1 macrophages as a proportion of all F4/80þ cells positively correlates with glomerulonephritis (GN). The line was fit by least-squares analysis,
with the derived equation, GN¼ 0.51þ (0.078Ly6ChiCCR2hi), R¼ 0.88, Po0.001. (b) The number of CD115þF4/80CD11bþ cells as a
percentage of all CD3CD19 mononuclear cells negatively correlated with GN. The line was fit by least-squares analysis, with the derived
equation, GN¼ 3.4—(0.054 CD115þ ), R¼  0.84, Po0.001.
934 Kidney International (2015) 87, 930–939
bas i c resea rch JJ Alexander et al.: CD11b in immune complex GN
There were CD3þ T lymphocytes in all kidneys, which
were either CD4þ or CD8þ (Figure 6a). Relative to all other
groups, the kidneys of CD11b / chimeras had an expanded
population of CD3þCD4þ cells (Figure 6a, red arrow). This
was unique to the kidney in these animals, as the spleens had
comparable numbers of lymphocytes (Figure 6b). Thus, the
absence of CD11b in either macrophages and/or dendritic cells
in mice with experimental GN was associated with increased
numbers of CD4þ T lymphocytes within the kidney.
DISCUSSION
In these studies, we induced CSS in CfH / BM chimeras.
ICs deposited in the glomeruli, around which C3 was
activated. In the absence of plasma CfH, active C3b
remained, capable of contributing to C5 cleavage.10 In this
setting, all animals developed renal functional impairment
and histopathological features of GN. The presence of iC3b
and F4/80þ macrophages in inflamed glomeruli9,10
supported our hypothesis that CD11b would be pathologic
in this model. Unexpectedly, CD11b / BM chimeric mice
had significantly worse renal disease than any other group.
This required the concomitant absence of plasma CfH, as
native CD11b / mice did not develop GN in CSS.
The CSS model used here relies upon repetitive admin-
istration with horse spleen apoferritin over 5 weeks, without
the use of adjuvant (hence, a nonaccelerated chronic active
autologous model). Actively immunized animals generated
anti-apoferritin IgG antibodies, which formed ICs with the
ongoing source of apoferritin antigen. Thus, it is not
surprising that the quantities of circulating ICs were related
to anti-apoferritin IgG. The measurement of the former
relied upon C1q binding, and it was independent from effects
of CfH or CD11b deficiencies on C3.
Complement activation in ICs leads to their incorporation
of C3b, which bind to cells with specific membrane receptors,
a phenomenon termed immune adherence by Nelson.18
Rodents, including mice, rely upon CfH on platelets,
whereas primates diverged to use CR1 on erythrocytes for
this particular immune function. ICs bound to platelet CfH
or erythrocyte CR1 are transported to hepatic macrophages
for elimination.19 This transfer is believed to occur because
these cells bear CR3 and FcgRs. CR3 has a greater binding
affinity for ICs bearing iC3b than does CfH (or CR1). In IC
processing, it is postulated that FcgRII is the most relevant, as
it is inhibitory and does not associate with FcRg.20 Consistent
with this premise, here we showed that FcRg / BM
chimeras had antibody and IC responses comparable to wild-
type chimeras.
In this disease model, glomerular ICs contain apoferritin,
IgG, and C3 components.21 As in our past studies,9 excessive
glomerular IC deposition occurred when mice lacked platelet
CfH, supporting that these formed from deposited ICs. Anti-
apoferritin IgG and IgG-containing ICs were highest in
CD11b / BM chimeric mice; although this did not
translate into a higher quantity of total glomerular ICs,
qualitatively there was greater extension into the peripheral
capillary wall. Yet, CD11b / mice with intact CfH were
largely indistinguishable from wild-type mice. Similar
CD11b-independent IC handling and exaggerated GN was
observed by the Mayadas group in an accelerated CSS
model.13 In their studies, neutrophils preceded macrophages
in glomeruli in a CD11b-dependent manner,13 a
phenomenon that we have not examined. Nonetheless,
taking these data together, glomerular IC deposition
appears to be largely independent from macrophage IC
handling. CfH / mice have an abnormally active humoral
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Figure 6 | Characterization of CD3þ cells in complement factor H (CfH) / mice chimeric for wild-type (WT), CfH / , FcgR / , and
CD11b / bone marrow immunized for 5 weeks with apoferritin, or saline as control. Representative data for CD4 (y-axis) and CD8
(x-axis) are shown from kidneys (a) and spleens (b). The red arrow depicts the expanded CD3þCD4þ population in CD11b / chimeras.
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immune response, which is exaggerated in the absence of
CD11b on BM-derived cells.
Diverse glomerular diseases are associated with substantial
accumulations of mononuclear cells in the TI. In fact, often
the strongest predictive variable of glomerular disease out-
come is the state of the TI.22–25 A limitation to assessing the
relative extent of GN in both animal models and in human
disease is the inherent subjectivity that goes into estimating
disease activity. In proliferative GN, such as our model used
here, higher scores largely reflect increased glomerular
cellularity. In contrast, the ability to accurately quantify cells
within the TI by flow cytometry has provided considerable
insight into the makeup of these cells in various disease
processes. Ly6ChiCCR2hi cells present in diseased tissue are
considered M1 (classically activated) macrophages.26,27 In this
study, there were increased numbers of M1 macrophages
in the TI of animals with CSS. The relationship between
glomerular and TI inflammation is supported by the strong
positive relationship between TI Ly6ChiCCR2hi cell numbers
and GN scores.
The surface marker staining of M1 macrophages as
Ly6ChiCCR2hiF4/80þCD11cþ was consistent across the
groups. In contrast, there were wide variations in CD11b
staining, with cells being CD11b , CD11bþ , or CD11bhi.
The clearest example of all three occurred in FcRg / BM
chimeras, in which approximately equal numbers of each was
present in the TI (see Figure 4c). The CD11b / BM
chimeric mice had solely CD11b M1 macrophages. From
our data presented here, we are unable to explain these
differences. Overall, we do feel that this illustrates the
importance of CD11b in macrophages to shape inflammatory
disease, for which we have evidence from other models.28
In our studies and those of several other groups, the
resident renal dendritic cell population is F4/80hiLy6C
CD11bþCD11cþ ;16,28,29in addition, as true here, they can be
separated into two groups with and without CCR2.28 The F4/
80hiLy6C population in CfH / mice chimeric for wild-
type BM were CD11bþ , whereas those with CD11b / BM
were CD11b , consistent with these dendritic cells being
radiosensitive and terminally differentiated. In these cells
lacking CD11b, there was greater surface expression of
CD11c. Although this may reflect that CD11c is the sole
binding partner for CD18 in these cells, it also may represent
a more activated phenotype.
The F4/80þLy6CþCCR2 cells were composed of two
distinct cellular populations, namely Ly6CþCD11bþ
CD11c and Ly6ChiCD11bCD11c . The former has
features consistent with alternatively activated macro-
phages.26,27,30 The latter cell type was prominent in CfH /
and FcRg / BM chimeras, including in the CfH /
BM controls. Thus, the physiological relevance of these
F4/80þLy6Chi cells is unclear. Yet, it does provide another
example of the interesting diversity of CD11b expression
among mononuclear cells.
The CD115þ cellular population was Ly6CF4/80
CD11c , but CD11bþ in all BM chimeras. This extended
to the CD11b / BM chimeras. Although there were lesser
quantities in the latter animal kidneys, their phenotypic
characteristics were otherwise comparable to the other
groups. Thus, this appears to be a radioresistant population
newly recruited from BM. Potentially this represents a
population within the myeloid-derived suppressor cell
family.31 As noted, these negatively predict disease. Here,
GN can be accurately predicted by the number of TI
CD115þ cells (in an inverse fashion) and measured BUN
values; it is noteworthy that each of these three variables was
arrived at by entirely separate means. Overall, this does
support the anti-inflammatory nature of these cells.
There was no remarkable expansion of CD3þ or CD19þ
lymphocytes in the kidneys or spleens of experimental or
control animals. The exception occurred with CD3þCD4þ T
cells in CD11b / BM chimeras. This did not occur in the
spleens of these animals, indicating the specificity of this
expansion to the kidney. In general, even though CD4þ T
cells can accumulate in the diseased sterile kidney, whether
this is antigen-dependent or -independent is unclear.32 In this
model, potential antigen-specific responses could occur to
apoferritin (accumulated in glomerular ICs) and/or to native
renal antigens from a break in tolerance. Alternatively, T-cell
accumulation could occur independent of antigen and T-cell
receptor.
There is growing appreciation that b2 integrins have roles
beyond cellular adhesion. The three b2 integrin (CD18)
partners are aL (CD11a), aM (CD11b), and aX (CD11c).
CD11b has the broadest set of potential ligands, including
iC3b and intercellular adhesion molecules (ICAM)-1 and 2,
which encompass those of CD11a and CD11c.33
Anaphylatoxin and chemokine receptor activation,
including C5aR, recruit Gia leading to ‘inside-out’
activation of CD11b and increased avidity for ligand34 such
as iC3b.35 When CD11b binds its ligand, it can generate
‘outside-in’ tyrosine kinase signals mediated by immuno-
receptor tyrosine-based activation motif proteins DAP12 and
FcgR. From these two, mononuclear phagocytic cells
primarily rely on DAP12.36 Of considerable interest is the
anti-inflammatory nature of these signals through CD11b.
For example, CD11b can limit proinflammatory signals
through Toll-like receptor 4 activation by E3 ubiquitin-
protein ligase CBL-B-mediated removal of activated
proteins.37,38 Taken together, it seems likely that CD11b
binding to the ligand is necessary for any anti-inflammatory
role. Plausible explanations include CD11b-ICAM1 binding
to divert CD11c-iC3b binding; CD11b occupying ICAM1 or
ICAM2 sites on dendritic cells that block T-cell CD11a
binding; and/or active signaling through macrophage CD11b.
The relevance of anti-inflammatory pathways brought about
by CD11b signaling is the topic of ongoing investigations by
us and others.
In summary, here we examined IC-mediated GN in
CfH / BM chimeric mice. The absence of plasma CfH in
all animals conferred susceptibility to GN. Compared with
wild-type, CfH / chimeric mice had increased glomerular
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ICs and higher BUN values, consistent with the role for
platelet CfH to process ICs. Disease in FcRg / chimeras
was no different from wild type, implying that the
immunoreceptor tyrosine-based activation motif-bearing
FcgRs (FcgRI and FcgRIII) are dispensible in this model. In
contrast, CD11b / chimeric mice had worsened histo-
pathological and functional disease compared with the other
groups; this required plasma CfH be absent, in which setting
greater quantities of iC3b ligand were generated. Disease in
CfH / mice chimeric for CD11b / BM was associated
with increased numbers of M1 macrophages and CD4þ T
lymphocytes in the renal interstitium. This occurred together
with an enhanced humoral immune response to the
heterologous antigen, suggesting local immune responses.
The population of interstitial CD115þCD11bþ cells was
associated with protection from GN. Thus, CD11b on
mononuclear cells is instrumental in generating an anti-
inflammatory response in the inflamed kidney.
MATERIALS AND METHODS
Animals
CD11b / mice generated by Mayadas et al.39 were obtained from
Jackson Laboratories (Bar Harbor, ME). FcRg / mice generated
by Sylvestre and Ravetch40 were obtained from Taconic
(Germantown, NY). CfH / mice were provided by Pickering
et al.14 All animals were backcrossed 410 generations onto normal
wild-type C57BL/6 mice (Jackson). The use of animals in these
studies was approved by the University of Chicago and University at
Buffalo Institutional Animal Care and Use Committees.
BM chimeric mice
CfH / mice between 4 and 6 weeks of age received 1050 cGy
(irradiation).9 BM cells were isolated by standard techniques from
femurs of wild-type, CfH / , FcRg / , or CD11b / mice, and
CD117þ (c-kitþ ) progenitor cells were isolated from BM cells using
a monoclonal antibody magnetic positive selection technique
(Miltenyi CD117 MicroBeads, Auburn, CA). One day after
irradiation, mice received 1106 CD117þ progenitor cells
intravenously. In our prior studies, this protocol rescued animals
from lethality and led to full hematopoietic reconstitution within 3
weeks.9
Chronic serum sickness model of immune complex–mediated
GN
Immune complex disease was induced by actively immunizing
chimeric mice 4 weeks after BM transfer with a daily intraperitoneal
dose of 4mg of horse spleen apoferritin (Calzyme Laboratories, San
Luis Obispo, CA). Controls were CfH / mice into which CfH /
mouse BM was transferred immunized with the same schedule of
saline vehicle alone. After 5 weeks, mice were killed and renal disease
was characterized.
Measurements from sera
Blood urea nitrogen concentrations were measured with a Beckman
Autoanalyzer (Beckman Coulter, Fullerton, CA). Serum anti-
apoferritin IgG antibodies were measured by enzyme-linked
immunosorbent assay.9 Briefly, 96-well plates were coated with
apoferritin. Serial dilutions of sera were plated and incubated at
room temperature for 2 h, followed by HRP-conjugated goat anti-
mouse IgG (Kierkegard & Perry Laboratories, Gaithersburg, MD)
and OPD peroxidase substrate (Sigma-Aldrich, St. Louis, MO). The
OD450 was then measured.
Circulating IC levels were measured by C1q-binding enzyme-
linked immunosorbent assay, as described previously.41 Briefly, 96-
well plates were coated with 10 mg/ml human C1q (Sigma-Aldrich)
in carbonate buffer. After blocking with 1% bovine serum albumin,
sera samples were loaded in serial dilutions starting at 1/1000,
followed by HRP-goat anti-mouse IgG (Sigma, 1:2000) and then
TMB (Jackson ImmunoResearch Laboratories, West Grove, PA).
The OD450 was then measured. Sera samples from unmanipulated
wild-type mice were used as negative control.
Immunofluorescence microscopy
Four-micrometer sections from frozen mouse kidneys were fixed in
ethanol:ether (1:1) for 10min followed by 95% ethanol for 20min
and washed with phosphate buffered saline. They were then stained
with fluorescein isothiocyanate–conjugated anti-mouse C3 (Cappel,
MP Biomedicals, Solon, OH) and Alexa 594–conjugated goat anti-
mouse IgG (Invitrogen, Life Technologies, Carlsbad, CA). Slides
were viewed with an Olympus BX-60 microscope (Melville, NY) and
scored in a masked manner from 0 to 4. Photomicrographs of
images representative of the group score were taken with a Zeiss
LSM 510 microscope (Carl Zeiss Microscopy, Jena, Germany) and
merged using the ZEN imaging software (Carl Zeiss Microscopy) at
identical settings. Images were imported as TIFF files into Photo-
shop CC (Adobe, San Jose, CA). The ‘transform scale’ function was
performed on all layers together, with width-to-height proportions
constrained.
Renal pathology
Tissues were fixed in 10% buffered formalin and embedded in
paraffin, from which 4-mm-thick sections were cut and stained with
periodic acid–Schiff. Each slide was scored in a blinded manner by a
renal pathologist (AC) for the extent of GN on a scale of 0 to 4 (in
increments of 0.5) according to the schema of Passwell et al.,42 as
described previously.10 In addition, the extent of interstitial
inflammation, interstitial fibrosis/tubular atrophy, and arteritis was
determined. Images representative of the group score were taken
similarly to those for immunofluorescence microscopy.
Flow cytometry
Single-cell suspensions were prepared from kidneys and spleens.
This approach is directed toward isolating cells within the kidney
wide interstitium; this anatomic space within the TI is between
tubules and vessels. Tissue was minced into small pieces (o1mm)
in ice-cold 1 Hank’s Balanced Salt Solution medium and incu-
bated with 1mg/ml collagenase (type IV, Sigma) and 0.1mg/ml
deoxyribonuclease (type I, Sigma) at 37 1C for 25min with gentle
shaking. The suspension was centrifuged at 250 g for 5min and the
pellet was resuspended in 2ml of 150mmol/l NH4Cl, 10mmol/l
KHCO3, 0.5mol/l ethylenediaminetetraacetic acid, pH 8 (erythro-
cyte lysing reagent), and incubated for 5min at room temperature.
The suspension was again centrifuged at 250 g for 5min, and the
supernatant was discarded. The cells were resuspended in 1–2ml of
ice-cold phosphate buffered saline containing 2% calf serum,
5mmol/l ethylenediaminetetraacetic acid, and 0.1% sodium azide
(FACS buffer) and passed through a 40-mm cell strainer. Cells were
resuspended at approximately 107/ml FACS buffer and incubated
with anti-CD16/32 (2.4G2) for 5min on ice before staining with
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specific antibodies. Cells were then washed with 1ml of FACS buffer,
centrifuged, resuspended in 200 ml of FACS buffer, and analyzed on a
flow cytometer (LSRII, BD, Franklin Lakes, NJ). Data were analyzed
using the FlowJo software (v. 10) (Ashland, OR).
Antibodies used for flow cytometry were APC-Cy7-conjugated
anti-mouse CD19 (Biolegend, San Diego, CA), brilliant violet 421–
conjugated anti-mouse CD3 (Biolegend), brilliant violet 605–conjugated
anti-mouse CD4 (Biolegend), Alexa fluor 488–conjugated anti-
mouse CD115 (Biolegend), PerCP5.5-conjugated anti-mouse Ly6C
(Biolegend), Alexa fluor 700–conjugated anti-CD11c (Biolegend),
V500-conjugated anti-mouse CD11b (BD), PE-Texas Red conju-
gated anti-mouse CD8 (Life Technologies), phycoerythrin-conju-
gated anti-mouse CCR2 (R&D Systems Minneapolis, MN), and
Alexa fluor 647–conjugated anti-F4/80 (AbD Serotec, Kidlington,
England, UK).
Statistical analyses
Numeric data were analyzed with the Minitab software (State College,
PA; v. 16.2.4). Normality of data was evaluated by Anderson–Darling
testing. Data are given as means±s.e.m. for parametric data and
medians with Q1–Q3 intervals for nonparametric data. In the
figures, data from individual mice are presented.
Univariate analysis of variance was used to compare experi-
mental parametric data. When the variances were significantly
different (Po0.05), follow-up comparisons were made with the
Tukey all-pairwise approach. To compare multiple groups of
nonparametric data, the Mood median test was used. Potential
correlations among data were determined by calculating Pearson’s
product moment correlation coefficients. Fitted line plots were
generated using the least-squares method. Subset models that
provided highest R2 values with least predictors were determined by
best subset regression.
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